Back

Explore every episode of the podcast Oncology Today with Dr Neil Love

Dive into the complete episode list for Oncology Today with Dr Neil Love. Each episode is cataloged with detailed descriptions, making it easy to find and explore specific topics. Keep track of all episodes from your favorite podcast and never miss a moment of insightful content.

Rows per page:

1–50 of 283

TitlePub. DateDuration
Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer24 Sep 202400:49:55
Dr Tiffany Traina from the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College in New York, New York, discusses optimizing the management of metastatic BRCA-negative, triple-negative breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayBRCANegTNBC24).
Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers20 Sep 202402:14:52
Dr Lipika Goyal from Stanford Cancer Center in Palo Alto, California, Dr James J Harding from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Robin K (Katie) Kelley from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, summarize the treatment landscape for patients with biliary tract cancers and review recent advancements in the field, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/BTCThinkTank2024).
An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer21 Aug 202400:52:36
Dr Angeles Alvarez Secord from the Duke Cancer Institute in Durham, North Carolina, provides her perspectives on recent datasets from ASCO 2024 on the management of ovarian and endometrial cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayASCOOvarianEndo24).
Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor23 Aug 202301:01:15
Dr Aditya Bardia from Massachusetts General Hospital in Boston, Massachusetts, and Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, discuss approved and novel treatment approaches for ER-positive metastatic breast cancer that has progressed on prior CDK4/6 inhibitor therapy. CME information and select publications here (https://researchtopractice.com/InsideTheIssue2023/ERPositivemBC).
Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management22 Aug 202301:00:50
Dr Hans Lee from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Saad Zafar Usmani from Memorial Sloan Kettering Cancer Center in New York, New York, discuss approved and novel bispecific antibodies and their current and potential roles in the treatment of multiple myeloma. CME information and select publications here (https://www.researchtopractice.com/InsidetheIssue2023/MM).
Special Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting21 Aug 202300:31:45
Dr Matthew Gubens from the University of California in San Francisco, California, discusses key presentations on lung cancer from the 2023 ASCO Annual Meeting moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://ResearchToPractice.com/OncologyTodayPostASCO23/Lung)
Special Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Chronic Lymphocytic Leukemia18 Aug 202301:09:21
Dr Kerry Rogers from the Ohio State University in Columbus, Ohio, discusses the education and care of patients with chronic lymphocytic leukemia. NCPD information and select publications here (https://www.researchtopractice.com/ONS2023CLLReview/InterviewAudio)
Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers 16 Aug 202301:03:38
Featuring perspectives from Dr Omid Hamid and Dr Evan J Lipson moderated by Dr Neil Love. Produced by Research to Practice. CME information and select publications here (http://www.researchtopractice.com/YiR2022/SkinCancers).
Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Gastrointestinal Cancers Issue15 Aug 202300:48:55
Dr Philip Philip from Henry Ford Cancer - Detroit in Michigan discusses key presentations on GI cancers from the 2023 ASCO Annual Meeting moderated by Dr Neil Love. Produced by Research to Practice. CME information and select publications here (https://researchtopractice.com/OncologyTodayPostASCO23/GI)
Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting11 Aug 202300:43:06
Dr Floor Backes from The James Cancer Hospital and Solove Research Institute in Columbus, Ohio, discusses recent updates from ASCO 2023 on the management of gynecologic cancers. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayPostASCO23/Gyn)
Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer — A Clinical Investigator Think Tank11 Aug 202302:48:57
Drs Neeraj Agarwal, Emmanuel Antonarakis, Karim Fizazi and Susan Slovin discuss the current and future role of PARP inhibitors in the management of prostate cancer. CME information and select publications here (https://www.researchtopractice.com/PARPProstateThinkTank2023).
Optimizing the Management of Metastatic Urothelial Bladder Cancer09 Aug 202301:02:03
Dr Terence Friedlander from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Petros Grivas from the Fred Hutchinson Cancer Research Center in Seattle, Washington, discuss available and novel treatment strategies for metastatic urothelial bladder cancer moderated by Dr Neil Love. CME informationa and select publications here (https://www.researchtopractice.com/InsideTheIssue2023/mUBC).
Special Edition — Current and Future Management of Breast Cancer08 Aug 202301:25:22
Dr Heather McArthur from the UT Southwestern Medical Center in Dallas, Texas discusses key presentations on breast cancer from the 2023 ASCO Annual meeting. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayPostASCO23/BreastCancer).
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer20 Aug 202401:01:23
Prof Solange Peters from the Lausanne University Hospital in Lausanne, Switzerland, and Professor Ben Solomon from the Peter MacCallum Cancer Centre in Melbourne, Australia, discuss treatment approaches for ALK-rearranged non-small cell lung cancer in the localized disease setting, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/InsideTheIssue2024/ALKPosNSCLC).
Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Ovarian Cancer Issue03 Aug 202300:57:26
Dr David O’Malley from The James Cancer Center in Columbus, Ohio, discusses recent advances in the management of ovarian cancer, including presentations from ASCO 2023. CME information and select publications here (https://researchtopractice.com/ASCO2023Ovarian/AudioInterview)
Special Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Colorectal and Gastroesophageal Cancers 02 Aug 202300:58:36
Dr Tanios Bekaii-Saab from the Mayo Clinic in Phoenix, Arizona, discusses the role of novel therapeutic management approaches for patients with colorectal and gastroesophageal cancers. NCPD information and select publications here (https://www.researchtopractice.com/ONS2023GE/AudioInterview)
Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes02 Aug 202301:03:06
Featuring perspectives from Dr Guillermo Garcia-Manero and Dr David Sallman. CME information and select publications here (https://www.researchtopractice.com/InsidetheIssue2023/MDS)
Immune Thrombocytopenia Edition with Dr Hanny Al-Samkari28 Jul 202300:29:23
Dr Hanny Al-Samkari from Harvard Medical School in Boston, Massachusetts, discusses the presentation and management of immune thrombocytopenia. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayITP23)
Paroxysmal Nocturnal Hemoglobinuria Edition with Dr Carlos de Castro25 Jul 202300:42:50
Dr Carlos de Castro from Duke Cancer Institute in Durham, North Carolina discusses the presentation, diagnosis and management of paroxysmal nocturnal hemoglobinuria. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayPNH23)
Special Edition — Management of Hepatobiliary Cancers24 Jul 202300:53:16
Dr Robin “Katie” Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California discusses recent updates from ASCO 2023 on the management of hepatobiliary cancers, moderated by Dr Neil Love. CME information and select publications here (http://www.ResearchToPractice.com/ASCO2023HBC/AudioInterview)
Special Edition — Management of Urothelial Bladder Cancer 21 Jul 202300:56:37
Dr Matthew Galsky discusses recent updates from ASCO 2023 on the management of urothelial bladder cancer moderated by Dr Neil Love. Produced by Research to Practice. CME information and select publications here (http://www.ResearchToPractice.com/ASCO2023Bladder/AudioInterview)
Special Edition — Current and Future Management of Breast Cancer21 Jul 202300:58:52
Featuring a discussion on recent presentations in breast cancer from the 2023 ASCO annual meeting with Dr Kevin Kalinsky moderated by Dr Neil Love. Produced by Research to Practice. CME information and select publications [here (http://www.ResearchToPractice.com/ASCO2023Breast/AudioInterview)
Special Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Urothelial Bladder Cancer20 Jul 202300:52:14
Dr Elizabeth Plimack from Fox Chase Cancer Center in Philadelphia, Pennsylvania, discusses available and emerging therapies for patients with urothelial bladder cancer. CME information and select publications here (https://www.researchtopractice.com/ONS2023Bladder/Audiointerview)
The Implications of New Research Findings for the Management of Endometrial Cancer14 Jul 202301:01:07
Featuring perspectives from Dr Bradley J Monk and Dr Matthew A Powell moderated by Dr Neil Love. Produced by Research to Practice. CME information and select publications here (http://www.researchtopractice.com/PostSGO23Endometrial).
Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer16 Aug 202400:54:17
Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, summarizes recent trials investigating the integration of antibody-drug conjugates for HR-positive and triple-negative metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayADCsmBC24).
Meet The Professor: The Current and Future Management of Hodgkin and Non-Hodgkin Lymphoma06 Jul 202301:01:14
Dr Ian W Flinn discusses the management of Hodgkin and non-Hodgkin lymphoma. CME information and select publications here (http://www.researchtopractice.com/MTPLymphoma23/)
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 1 of a 2 - Part Series16 Jun 202301:01:23
Dr Brian Van Tine discusses new and future research in the management of soft tissue sarcoma and related connective tissue disorders. CME information and select publications here (http://www.researchtopractice.com/MTPSarcoma23/Part1)
Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Multiple Myeloma Edition19 Apr 202301:14:38
Dr Jacob Laubach from the Dana-Farber Cancer Institute discusses key presentations in multiple myeloma from the 2022 ASH Annual Meeting. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPostASH23/MM).
Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Chronic Lymphocytic Leukemia Edition12 Apr 202301:17:00
Dr John Allan from Weill Cornell Medicine in New York City discusses the most important chronic lymphocytic leukemia studies presented at ASH 2022. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPostASH23/CLL).
Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting with Dr Matthew Lunning02 Mar 202301:28:06
Dr Matthew Lunning from the University of Nebraska Medical Center in Omaha, Nebraska, discusses the most important lymphoma studies presented at the 2022 ASH Annual Meeting. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPostASH23/Lymphoma).
Management of Desmoid Tumors with Dr Mrinal Gounder28 Feb 202300:54:17
Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York City discusses the management of desmoid tumors. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayDesmoidTumors22).
Management of HER2-Altered Non-Small Cell Lung Cancer21 Feb 202301:19:55
Dr Bob Li from Memorial Sloan Kettering Cancer Center in New York City discusses the current and future roles of targeted therapy for HER2-altered non-small cell lung cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayHER2AlteredNSCLC22).
Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation13 Feb 202300:49:30
Dr Edward Garon from the UCLA Jonsson Comprehensive Cancer Center in Los Angeles, California, discusses the management of NSCLC in patients who do not have actionable activating mutations. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayNSCLCwithoutActionableMutation22).
Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting — With Dr Srdan Verstovsek09 Feb 202301:19:02
Dr Srdan Verstovsek from the University of Texas MD Anderson Cancer Center in Houston, Texas, discusses new data with myeloproliferative neoplasms presented at the 2022 ASH Annual Meeting. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPostASH23/MPN).
Advances in Diffuse Large B-Cell Lymphoma with Dr Gilles Salles06 Feb 202300:43:31
Dr Gilles Salles from Memorial Sloan Kettering Cancer Center in New York City discusses recent data from clinical trials evaluating targeted therapies for diffuse large B-cell lymphoma. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayDLBCL22).
Novel Agents and Strategies in Lung Cancer13 Aug 202401:01:43
Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Ticiana Leal from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Manish Patel from Florida Cancer Specialists & Research Institute in Sarasota, Florida, summarize recently presented advancements, including novel strategies, in the treatment of lung cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/OncologyToday24/NovelLung).
Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting with Dr Richard Stone02 Feb 202301:10:01
Dr Richard Stone from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses new data in acute myeloid leukemia and myelodysplastic syndromes presented at the 2022 ASH Annual Meeting. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPostASH23/AMLMDS).
Special Edition — Management of ER-Positive Breast Cancer with Drs Erica Mayer and Ruth O'Regan31 Jan 202301:39:57
Dr Erica Mayer from the Dana-Farber Cancer Institute in Boston, Massachusetts and Dr Ruth O'Regan from the University of Rochester in Rochester, New York discuss new developments in ER-positive breast cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayERPositiveBreastCancer23).
HER2-Positive Metastatic Breast Cancer with Professor Giuseppe Curigliano26 Jan 202300:46:57
Professor Giuseppe Curigliano from the European Institute of Oncology in Milan, Italy discusses recent therapeutic advances in HER2-positive metastatic breast cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayHER2PositivemBC22).
Management of Gastroesophageal Cancers with Dr Manish Shah12 Jan 202300:43:16
Dr Manish Shah from Weill Cornell Medicine in New York City discusses current approaches to the management of upper GI malignancies and the potential future role of novel therapies for patients with these cancers.  CME information and select publications here (http://www.researchtopractice.com/OncologyTodayGastroesophageal22).
Managing Metastatic Urothelial Bladder Cancer with Dr Scott Tagawa05 Jan 202300:56:00
Dr Scott Tagawa from Weill Cornell Medicine Sandra and Edward Meyer Cancer Center in New York, New York discusses current treatments and management strategies for metastatic urothelial bladder cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayMetastaticBladderCancer22).
Role of PARP Inhibition in Ovarian Cancer with Dr Thomas Herzog21 Dec 202200:49:58
Dr Thomas Herzog from the University of Cincinnati Medical Center in Cincinnati, Ohio, discusses updates and recent changes in the use of PARP inhibitors for ovarian cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayOvarianPARP22).
Novel Immunotherapeutic Strategies in Melanoma with Dr Omid Hamid13 Dec 202200:49:50
Dr Omid Hamid from the Angeles Clinic and Research Institute in Los Angeles, California, discusses novel immunotherapies and combination treatments for patients with metastatic melanoma. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayNovelStrategiesMelanoma22).
Thyroid Cancer with Dr Eric Sherman08 Dec 202201:08:58
Dr Eric Sherman from Memorial Sloan Kettering Cancer Center in New York City discusses recent therapeutic advances in thyroid cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayThyroid22).
Amyloid Light Chain (AL) Amyloidosis with Dr Jeffrey Zonder06 Dec 202200:42:17
Dr Jeffrey Zonder from Karmanos Cancer Institute in Detroit, Michigan discusses the biology, presentation and current management of AL amyloidosis and emerging data with novel therapies. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayALAmyloidosis22).
Novel Agents and Strategies in Myelofibrosis with Dr Ruben Mesa01 Dec 202200:41:29
Dr Ruben Mesa from the Mays Cancer Center in San Antonio, Texas, discusses therapeutic advances in the management of patients with myelofibrosis. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayNovelAgentsMF22).
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma09 Aug 202401:02:03
Dr Jesús G Berdeja from the Greco-Hainsworth Tennessee Oncology Centers for Research in Nashville and Dr Thomas Martin from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco discuss the most relevant new data sets and advances in multiple myeloma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/MM).
Management of Renal Cell Carcinoma with Dr Toni Choueiri29 Nov 202200:40:27
Dr Toni Choueiri from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent therapeutic advances in the care of patients with renal cell carcinoma. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayRCC22).
Management of Hepatocellular Carcinoma with Prof Arndt Vogel21 Nov 202200:59:20
Professor Arndt Vogel from Hannover Medical School in Germany discusses major clinical trials and recent changes in the treatment of advanced hepatocellular carcinoma. CME information and select publications [here] (http://www.researchtopractice.com/OncologyTodayHCC22)
Novel Agents and Strategies in AML with Dr Eytan Stein17 Nov 202200:28:25
Dr Eytan Stein from Memorial Sloan Kettering Cancer Center in New York City discusses novel agents and strategies in the treatment of acute myeloid leukemia. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayNovelAgentsAML22).
© My Podcast Data
About usPrivacy Policy